Researchers continue to excited about the medication , a innovative dual compound showing promising results in early trials for size reduction . It acts by targeting both systems: GLP-1 and GIP, which , https://kallumgxqj893542.verybigblog.com/39632767/this-new-hope-for-weight-loss